These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 3500056)
1. A phenotypically dominant regulatory mechanism suppresses major histocompatibility complex class II gene expression in a murine plasmacytoma. Venkitaraman AR; Culbert EJ; Feldmann M Eur J Immunol; 1987 Oct; 17(10):1441-6. PubMed ID: 3500056 [TBL] [Abstract][Full Text] [Related]
2. Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells. Sartoris S; Tosi G; De Lerma Barbaro A; Cestari T; Accolla RS Eur J Immunol; 1996 Oct; 26(10):2456-60. PubMed ID: 8898960 [TBL] [Abstract][Full Text] [Related]
3. Inducible and constitutive MHC class II gene expression. Distinct tissue-specific genetic controls. Sartoris S; Scupoli MT; Scarpellino L; Paiola F; Jotterand-Bellomo M; Tridente G; Accolla RS J Immunol; 1990 Sep; 145(6):1960-7. PubMed ID: 2391425 [TBL] [Abstract][Full Text] [Related]
4. Distinct mechanisms regulate MHC class II gene expression in B cells and macrophages. Maffei A; Scarpellino L; Bernard M; Carra G; Jotterand-Bellomo M; Guardiola J; Accolla RS J Immunol; 1987 Aug; 139(3):942-8. PubMed ID: 3110290 [TBL] [Abstract][Full Text] [Related]
5. Regulation of class II gene expression in a murine pre-B cell line. Polla BS; Poljak A; Geier S; Nathenson SG; Ohara J; Paul WE; Glimcher LH Fed Proc; 1986 Dec; 45(13):2995-9. PubMed ID: 3536599 [TBL] [Abstract][Full Text] [Related]
6. Immune dysfunction in mice with plasmacytomas. I. Evidence that transforming growth factor-beta contributes to the altered expression of activation receptors on host B lymphocytes. Berg DJ; Lynch RG J Immunol; 1991 Apr; 146(8):2865-72. PubMed ID: 1826699 [TBL] [Abstract][Full Text] [Related]
7. DNA-mediated transfer of major histocompatibility class II I-Ab and I-Abm12 genes into B lymphoma cells: molecular and functional analysis of introduced antigens. Ben-Nun A; Choi E; McIntyre KR; Leeman SA; McKean DJ; Seidman JG; Glimcher LH J Immunol; 1985 Aug; 135(2):1456-64. PubMed ID: 3925010 [TBL] [Abstract][Full Text] [Related]
8. Complex regulation of class II gene expression: analysis with class II mutant cell lines. Glimcher LH; McKean DJ; Choi E; Seidman JG J Immunol; 1985 Nov; 135(5):3542-50. PubMed ID: 2995495 [TBL] [Abstract][Full Text] [Related]
9. Mutant human B cell lines deficient in class II major histocompatibility complex transcription. Calman AF; Peterlin BM J Immunol; 1987 Oct; 139(7):2489-95. PubMed ID: 3116083 [TBL] [Abstract][Full Text] [Related]
10. Regulation of the expression of multiple class II genes in murine B cells by B cell stimulatory factor-1 (BSF-1). Noelle RJ; Kuziel WA; Maliszewski CR; McAdams E; Vitetta ES; Tucker PW J Immunol; 1986 Sep; 137(5):1718-23. PubMed ID: 3489040 [TBL] [Abstract][Full Text] [Related]
11. Changes in the phenotype and immunoglobulin secretion of human B cells following co-culture with cells of an EBV+ lymphoblastoid line or fusion with mouse plasmacytoma cells. Studies in short-term and long-term culture. Ling NR; Lowe JA Clin Exp Immunol; 1989 Feb; 75(2):311-6. PubMed ID: 2539279 [TBL] [Abstract][Full Text] [Related]
12. MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance? Walter W; Lingnau K; Schmitt E; Loos M; Maeurer MJ Br J Cancer; 2000 Nov; 83(9):1192-201. PubMed ID: 11027433 [TBL] [Abstract][Full Text] [Related]
13. Transcriptional control of MHC class II gene expression during differentiation from B cells to plasma cells. Dellabona P; Latron F; Maffei A; Scarpellino L; Accolla RS J Immunol; 1989 Apr; 142(8):2902-10. PubMed ID: 2495328 [TBL] [Abstract][Full Text] [Related]
14. Cell-surface expression of human histocompatibility leucocyte antigen (HLA) class II-associated invariant chain (CD74) does not always correlate with cell-surface expression of HLA class II molecules. Wilson KM; Labeta MO; Pawelec G; Fernandez N Immunology; 1993 Jun; 79(2):331-5. PubMed ID: 8344710 [TBL] [Abstract][Full Text] [Related]
15. Anti-class II antibodies, but not cytotoxic T-lymphocyte antigen 4-immunoglobulin hybrid molecules, prevent rejection of major histocompatibility complex class II-negative myeloma in T-cell receptor-transgenic mice. Dembic Z; Hofgaard PO; Omholt H; Bogen B Scand J Immunol; 2004; 60(1-2):143-52. PubMed ID: 15238083 [TBL] [Abstract][Full Text] [Related]
16. Mixed haplotype A beta Z/A alpha d class II molecule in (NZB x NZW)F1 mice detected by T cell clones. Gotoh Y; Takashima H; Noguchi K; Nishimura H; Tokushima M; Shirai T; Kimoto M J Immunol; 1993 Jun; 150(11):4777-87. PubMed ID: 8496588 [TBL] [Abstract][Full Text] [Related]
17. Comparison of antigen specificity, class II major histocompatibility complex restriction, and in vivo behavior of myelin basic protein-specific T cell lines and clones derived from (BALB/c x SJL/J) mice. Trotter J; Zamvil SS; Steinman L J Immunol; 1987 Sep; 139(6):1834-9. PubMed ID: 2442257 [TBL] [Abstract][Full Text] [Related]
18. Establishment of cell lines from somite stage mouse embryos and expression of major histocompatibility class I genes in these cells. Silverman T; Rein A; Orrison B; Langloss J; Bratthauer G; Miyazaki J; Ozato K J Immunol; 1988 Jun; 140(12):4378-87. PubMed ID: 2453581 [TBL] [Abstract][Full Text] [Related]
19. Hybrid cells formed by fusion of Epstein-Barr virus-associated B-lymphoblastoid cells and either marrow-derived or solid tumour-derived cell lines display different co-stimulatory phenotypes and abilities to activate allogeneic T-cell responses in vitro. Cywinski AL; Dunnion DJ; Teobald I; Tucker VC; Browning MJ Tissue Antigens; 2006 Aug; 68(2):115-26. PubMed ID: 16866881 [TBL] [Abstract][Full Text] [Related]
20. Expression of MHC class II antigens in human B-cell leukaemia, and increased levels of class II antigens and DR-specific mRNA after stimulation with 12-O-tetradecanoyl phorbol-13-acetate. Guy K; Meehan RR; Dewar AE; Larhammar D Immunology; 1986 Feb; 57(2):181-8. PubMed ID: 3512424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]